ELIOT RICHARD FORSTER, PH.D.

Corporate Board Profile

Tech Score: 0/100

Protalix BioTherapeutics, Inc.

Filing Date	Source Excerpt
2024-04-29	Eliot Richard Forster, Ph.D. Dr. Forster joined our Board of Directors as its Chairman in September 2023. ... The Board of Directors has determined that neither Dr. Forster ... is an “independent director” ... The position of Chairman of the Board is not held by our chief executive officer at this time. ... The membership of each committee is as follows: ... Nominating Committee Chairman: Amos Bar Shalev; Membership: Amos Bar Shalev, Eliot Richard Forster, Ph.D., and Aharon Schwartz, Ph.D. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2023. ... Dr. Forster’s tenure on our Board of Directors commenced on September 14, 2023. ... Fees Earned or Paid in Cash ($): 20,806; Option Award(s) ($): 27,182; Total ($): 47,988.

Filing Date

Source Excerpt

2024-04-29

Eliot Richard Forster, Ph.D. Dr. Forster joined our Board of Directors as its Chairman in September 2023. ... The Board of Directors has determined that neither Dr. Forster ... is an “independent director” ... The position of Chairman of the Board is not held by our chief executive officer at this time. ... The membership of each committee is as follows: ... Nominating Committee Chairman: Amos Bar Shalev; Membership: Amos Bar Shalev, Eliot Richard Forster, Ph.D., and Aharon Schwartz, Ph.D. ... The following table sets forth information with respect to compensation of our non-employee directors during fiscal year 2023. ... Dr. Forster’s tenure on our Board of Directors commenced on September 14, 2023. ... Fees Earned or Paid in Cash ($): 20,806; Option Award(s) ($): 27,182; Total ($): 47,988.

Data sourced from SEC filings. Last updated: 2026-02-08